Skip to content

Quick ratio at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
0.8×-0.3×
Merck & Co. logo
Merck & Co.MRK
1.1×-0.2×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
6.4×+4.3×
UroGen Pharma logo
UroGen PharmaURGN
4.3×-1.2×
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
10.7×-3.2×
CG Oncology logo
CG OncologyCGON
31.3×+0.3×

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Calculated from Aura Biosciences, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s quick ratio?
Aura Biosciences, Inc. (AURA) reported quick ratio of 7.1× in Q1 2026.
How has Aura Biosciences, Inc.'s quick ratio changed year-over-year?
Aura Biosciences, Inc.'s quick ratio decreased by 35.9% year-over-year, from 11.1× to 7.1×.
What is the long-term trend for Aura Biosciences, Inc.'s quick ratio?
Over 5 years (2020 to 2025), Aura Biosciences, Inc.'s quick ratio has grown at a 3.3% compound annual growth rate (CAGR), from 6.9× to 8.1×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.